LAmB, a unilamellar liposomal formulation of amphotericin B, demonstrates excellent efficacy against leishmaniasis, likely due to its selective uptake by the mononuclear phagocyte system (MPS), particularly by macrophages, as part of innate immunity. Here, GRAMD1B is linked to leishmaniasis.